2 target-tracking positions at UNICAM

Local nanoparticle-mediated drug delivery for effective osteosarcoma- targeted therapy (OsteoTher)

UNICAM | Italy | 2 months ago

factors to reprogram TAMs from pro-tumoral (M2) to anti-tumoral (M1) phenotypes. NCs are engineered for targeted delivery via CD-206 and CD-44 receptors, with controlled release at the tumor site

Development of cebranopadol, a potent dual MOP/NOP agonist, for the treatment of Opioid Use Disorder (OUD)

UNICAM | Italy | about 1 month ago

novel MOP/NOP dual receptor agonist, as a safer and more effective treatment for opioid use disorder (OUD). Unlike current OUD therapies that target only MOP receptors, cebranopadol's dual mechanism has